(2S)-4-(3-Pyridyl)-1,2-O-isopropylidenebutane-1,2-diol | 192376-46-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2S)-4-(3-Pyridyl)-1,2-O-isopropylidenebutane-1,2-diol
• 英文别名: 3-[2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]ethyl]pyridine
• CAS: 192376-46-8
• 化学式: C₁₂H₁₇NO₂
• 分子量: 207.272
• InChiKey: IFWKSBBFEZQRPE-NSHDSACASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  31.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2S)-4-(3-Pyridyl)-1,2-O-isopropylidenebutane-1,2-diol 以 盐酸 为溶剂， 生成 (2S)-4-(pyridin-3-yl)-1,2-butanediol
  参考文献：
  名称：

  Pyridine derivatives and pharmaceutical compositions containing them

  摘要：

  该发明涉及新的吡啶衍生物，它们的用途作为药物，包括它们的药物制剂和制备方法。

  公开号：

  US06265409B1

文献信息

• Compounds
  申请人：Astra Pharmaeuticals Ltd.

  公开号：US05977105A1

  公开（公告）日：1999-11-02

  A compound of formula I, ##STR1## wherein--X represents (CH.sub.2).sub.n O, (CH.sub.2).sub.n S or C.sub.2 alkylene; n represents 1 or 2; Ar.sup.1 represents indanyl, tetrahydronaphthyl, naphthyl or phenyl, which latter two groups may be substituted by one or more substituents selected from chloro, fluoro, OR.sup.1, O(CH.sub.2).sub.m CONR.sup.20 R.sup.21, C(O)R.sup.2, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms), pyridyl, thiazinyl, phenyl or C.sub.7-9 alkylphenyl which latter two groups are optionally substituted by one or more substituent selected from halo, nitro, OR.sup.3, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms), C(O)R.sup.4, C(O)OR.sup.5, C(O)N(R.sup.6)R.sup.7, CN, CH.sub.2 OR.sup.14, CH.sub.2 NR.sup.15 R.sup.16, N(R.sup.8)R.sup.9, N(R.sup.10)SO.sub.2 R.sup.11, N(R.sup.12)C(O)R.sup.13, OC(O)R.sup.19 and SO.sub.2 NR.sup.17 R.sup.18 ; m represents an integer 1 to 3; R.sup.1, R.sup.2 and R.sup.3 independently represent H, C.sub.1-10 alkyl (optionally substituted by one or more fluorine atoms), C.sub.7-9 alkylphenyl or phenyl, which latter group is optionally substituted by hydroxy; and R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13, R.sup.14, R.sup.15, R.sup.16, R.sup.17, R.sup.18, R.sup.19, R.sup.20 and R.sup.21 independently represent H, C.sub.1-6 alkyl (optionally substituted by one or more fluorine atoms) or phenyl; in which any alkyl group present may be interrupted by one or more oxygen atoms; provided that when X represents CH.sub.2 CH.sub.2, Ar.sup.1 may not represent phenyl or phenyl substituted with one or more substituents OR.sup.1, in which R.sup.1 represents C.sub.1-10 alkyl; or a pharmaceutically acceptable derivative thereof, may be used for the treatment of a reversible obstructive airways disease or allergic conditions of the skin, nose and eye.

  一种具有以下结构式I的化合物，其中--X代表(CH₂)ₙO，(CH₂)ₙS或C₂烷基；n代表1或2；Ar¹代表茚基、四氢萘基、萘基或苯基，后两种基团可以被来自氯、氟、OR¹、O(CH₂)ₘCONR²⁰R²¹、C(O)R²、C₁-₆烷基（可选地被一个或多个氟原子取代）、吡啶基、噻唑基、苯基或C₇-₉烷基苯基的一个或多个取代基所取代；后两种基团可以被来自卤素、硝基、OR³、C₁-₆烷基（可选地被一个或多个氟原子取代）、C(O)R⁴、C(O)OR⁵、C(O)N(R⁶)R⁷、CN、CH₂OR¹⁴、CH₂NR¹⁵R¹⁶、N(R⁸)R⁹、N(R¹⁰)SO₂R¹¹、N(R¹²)C(O)R¹³、OC(O)R¹⁹和SO₂NR¹⁷R¹⁸所选取的一个或多个取代基所取代；m代表整数1到3；R¹、R²和R³独立地代表H、C₁-₁₀烷基（可选地被一个或多个氟原子取代）、C₇-₉烷基苯基或苯基，后一基团可选地被羟基取代；R⁴、R⁵、R⁶、R⁷、R⁸、R⁹、R¹⁰、R¹¹、R¹²、R¹³、R¹⁴、R¹⁵、R¹⁶、R¹⁷、R¹⁸、R¹⁹、R²⁰和R²¹独立地代表H、C₁-₆烷基（可选地被一个或多个氟原子取代）或苯基；其中任何存在的烷基基团可以被一个或多个氧原子中断；但是当X代表CH₂CH₂时，Ar¹不能代表苯基或被一个或多个取代基OR¹取代的苯基，其中R¹代表C₁-₁₀烷基；或其药学上可接受的衍生物，可用于治疗可逆性阻塞性气道疾病或皮肤、鼻子和眼睛的过敏症状。
• NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：AstraZeneca AB

  公开号：EP0984961B1

  公开（公告）日：2001-06-20
• US5977105A
  申请人：——

  公开号：US5977105A

  公开（公告）日：1999-11-02
• US6143751A
  申请人：——

  公开号：US6143751A

  公开（公告）日：2000-11-07
• US6265409B1
  申请人：——

  公开号：US6265409B1

  公开（公告）日：2001-07-24